Google+ Facebook Twitter Twitter

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

The outbreak affected only children under the age of 10. Within a year, more than 1000 children from 35 countries with hepatitis of unknown origin were reported to the World Health Organization. In 12 months, cases seemed to stop just as quickly as they appeared.

The study found it was caused by an infection of different viruses at the same time, but also revealed cases were higher and more severe than initially thought.

“When the outbreak unfolded, the increase of cases was baffling; it was intriguing as to how these cases occurred and why there were cases from the UK as well as cases from the US,” said co-author Professor Guy Eslick from the University of Sydney.

The team pooled evidence from all available studies reporting on cases of hepatitis of unknown origin, where doctors were unable to determine the cause. They found that the number of cases was higher and more severe than initially thought, with the data covering 33 reports and more than 3000 cases. The mortality rate was 3.5%.

There was also strong evidence supporting a leading theory the hepatitis was caused by infection of different viruses at the same time.

A common childhood virus called adeno-associated virus 2 (AAV2) was present in blood and tissue samples from the majority of children with unexplained hepatitis, and many were infected by multiple “helper viruses”.

The timing of the outbreak and the COVID-19 pandemic potentially also played a role. After COVID-19 pandemic restrictions were lifted, young children who had been isolated had immune systems less trained to fight off common childhood infections.

Image Credit | Science Photo Library

Related Articles

Doctor's hands vaccinating a woman stock photo CREDIT-iStock-1444188743

A universal vaccine?

Scientists have demonstrated a new, RNA-based vaccine strategy that is effective against any strain of a virus and can be used safely even by babies and the immunocompromised.

Two Scientist Microscope images and video- istock-1363238207

Enzymes open new path to universal donor blood

The quest to develop universal donor blood has taken a decisive step forward, it is claimed.

Pseudomonas aeruginosa bacteria - CREDIT - Science-Photolibrary-f0280202

New five-year plan to combat antimicrobial resistance

The government’s national action plan will commit the UK to reducing its use of antimicrobials – such as antibiotics, antifungals and antivirals – in humans and animals, strengthen surveillance of drug-resistant infections before they emerge and incentivise industry to develop the next generation of treatments.


Sponsored: Time is of the essence in the management of sepsis

Every year, 49 million people acquire sepsis. Time is of the essence for appropriate therapy as the key driver of clinical outcomes.